Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.
about
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapyEfficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TIA single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancerChemotherapy advances in locally advanced head and neck cancerRecurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy.Helical tomotherapy in head and neck cancer: a European single-center experience.Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis.The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma.The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy.Systemic therapy strategies for head-neck carcinomas: Current statusOutcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan.A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck.New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011.Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?Concurrent chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy (sequential approach) in the management of head and neck cancer.Hazards and risks in oncology: radiation oncology.Induction chemotherapy followed by concurrent chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma with HPV and P16 testing.Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM.Pharmacotherapy of head and neck cancer.ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic reviewEfficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study.Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma.Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines.Comparison of three different concurrent chemoradiation regimens for treatment of laryngeal cancer.Sequential TPF chemotherapy followed by concurrent chemoradiotherapy in locally advanced head and neck cancer--a retrospective analysis of toxicity and outcomes.Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience.Feasibility and tolerance of sequential chemoradiotherapy in squamous cell carcinoma of the head and neck.A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.[No improvement in survival with induction chemotherapy prior to chemotherapy in locally advanced head and neck cancer: Results of a randomised phase 3 trial (PARADIGM)].Radiotherapy for locally advanced resectable T3-T4 laryngeal cancer-does laryngeal preservation strategy compromise survival?AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.[Main results of studies on primary therapy of head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014].Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Role, Controversy, and Future Directions.Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription.Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
P2860
Q24235245-0E517783-1D91-4ABB-B423-B20D4620AE39Q33858049-C6A8A156-973C-4EA1-9700-402424FBF21FQ34452702-6B697BF9-0259-4639-93B0-2806402DCBD2Q34498577-30B1EE7D-FBB0-41E2-B5A1-A92BFE339184Q34657763-099880B8-09F6-462E-9F56-197A25ED36C3Q35081204-085E9C70-698E-456A-8922-DD052C1A147FQ35151101-B223CBE9-5832-48EE-B389-0CD6C1BB6163Q35652246-088BCD70-4C01-45F4-B60B-C86ABB0AA6D2Q35845864-5CD86E03-9606-4AAD-B894-9CDD10AF5379Q36403236-D1A0F042-F0FB-41BA-B251-D9290E475828Q36407111-3285DCF4-EAD3-485B-8164-7D806F300217Q36529843-5AB20F4E-9AC8-439B-B6A7-CAB848C387BCQ37206229-353485E4-28A9-46E7-AF08-6385A6795E65Q37322374-EAF69190-7B79-4E6B-A318-0CF35BFF48C5Q37996835-7EF217FF-8631-44C6-963B-C6D7024637E6Q38084760-6E5296A4-6F1A-4EC9-85ED-FB70D9E9D33BQ38139996-795D092E-D2A4-40E1-8F92-29EC2C9111A0Q38176904-D55CF1CA-A06D-41FB-A334-1C217E2076E5Q38200954-EB2E7467-122F-4667-AE95-C0CB231A26E4Q38285974-05B1280D-DE44-4ECB-AAF5-110BF3800C3FQ38619293-1464DAF5-8B4A-464E-A6CE-433132388EB1Q38850017-E3F6A233-8427-4FD4-B6B6-3561C9C5DC11Q38855117-8ABA355A-9EF4-463A-A5B2-B92AD7E7867DQ39193669-85C4F034-D9A5-48FF-B387-8DC6D90AB49CQ39663607-CBFB99F1-4C20-4FCC-8605-74519D4FDF5BQ40100374-AB30EE1F-CAFE-4546-884B-409CD706BD9CQ40195131-BE3B5936-2EC7-4489-9F38-10BA7BC2033DQ40221340-E094BBAD-D53F-4F5B-9B6E-F05142FAE9F1Q41646543-A60438FB-787F-4CD2-AC88-3AC2623FB6D7Q43650000-696306A1-5B6D-4272-8497-36EEC93857B1Q43821393-13934411-3C7D-4018-99A3-40A46B7CE9BEQ44468804-EDC5693F-48A0-4D5E-BE2B-ABB30ECFCEE1Q47282066-426B418C-80D0-4101-85A6-D9AA3BAE66E1Q48240243-B924C8C9-72A0-4F64-9F67-9BB26F63BEEAQ49882298-38A5FEDF-490D-44FD-A261-865CC24DB45EQ50660925-9A442FB6-52A0-4FE7-ABBB-D42D09F17605Q51260016-2A3E0D18-3232-476D-8035-93A77969FF44Q52596125-8C3F8099-8916-45E4-9953-655FE03500BEQ53143666-DCDBE8B4-931C-4B31-9C3A-B82A20535FD2Q53579981-71BC9C3F-0016-4ED3-99F0-67E5D7BBA350
P2860
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Concomitant chemoradiotherapy ...... : a phase II randomized study.
@en
Concomitant chemoradiotherapy ...... : a phase II randomized study.
@nl
type
label
Concomitant chemoradiotherapy ...... : a phase II randomized study.
@en
Concomitant chemoradiotherapy ...... : a phase II randomized study.
@nl
prefLabel
Concomitant chemoradiotherapy ...... : a phase II randomized study.
@en
Concomitant chemoradiotherapy ...... : a phase II randomized study.
@nl
P2093
P2860
P356
P1433
P1476
Concomitant chemoradiotherapy ...... r: a phase II randomized study
@en
P2093
A Ardizzoia
A Paccagnella
F Campostrini
Gruppo di Studio Tumori della Testa e del Collo XRP 6976 F/2501 Study
P2860
P304
P356
10.1093/ANNONC/MDP573
P577
2009-12-23T00:00:00Z